bioAffinity Technologies Alternatives & Competitors
12 companies similar to bioAffinity Technologies — Addressing a critical need to find cancer early and treat cancer at the cellular...
Companies similar to bioAffinity Technologies
VisionGate, Inc.
Leading the Battle Against Lung Cancer through our Early Detection Technology
Phoenix, United States
LungLife AI
LungLife AI is transforming lung cancer diagnosis and management through AI-enabled analys...
Thousand Oaks, United Sta...
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; c...
Australia
Travera
Revolutionizing Cancer Therapy Guidance.
Medford, United States
Rival Readout
Competing with bioAffinity Technologies? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
The Royal Marsden NHS Foundation Trust
Life demands excellence
London, United Kingdom
Cleveland Diagnostics
Cleveland Diagnostics is a cancer biotechnology company that is changing the shape of canc...
Cleveland, United States
OncXerna Therapeutics
Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...
Waltham, United States
Epi One
Taking Cancer Diagnosis to the Next Level
Brooklyn, United States
KeyZell
We developed for the first time an innovative and effective AI system for precision medici...
Sevilla, Spain
ARNA Genomics
Pioneering early cancer diagnosis through advanced fluid biopsy technology
ACT Genomics
Make Personalized Medicine Accessible To All.
Taiwan
Marseille, France
About bioAffinity Technologies
bioAffinity Technologies is a biotechnology company based in the United States, founded in 2014. The company focuses on addressing the critical need to detect and treat cancer at the cellular level, particularly targeting early-stage lung cancer and other lung diseases. Their flagship product, CyPath® Lung, is a noninv...
Cancer Diagnosis, Lung Cancer Detection, Noninvasive Testing, Precision Medicine, Cellular Level Treatment, Early-stage Cancer Diagnosis, Diagnostic Accuracy, Noninvasive Therapies, Global Healthcare, Biomarker Technology, Oncology Innovations, Pulmonary Nodule Detection, Healthcare Advancements
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around bioAffinity Technologies: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at bioAffinity Technologies on 15 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 20 Oct 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
